Literature DB >> 16197614

Molecular effects of the isoflavonoid genistein in prostate cancer.

Jasmin Bektic1, Roman Guggenberger, Iris E Eder, Alexandre E Pelzer, Andreas P Berger, Georg Bartsch, Helmut Klocker.   

Abstract

Differences in diet have been proposed to be at least partially responsible for the low rate of prostate cancer in Asian populations compared with men in Western countries. One of the compounds that occurs in a greater quantity in the Eastern diet is genistein, an isoflavonoid found in high concentrations in serum after ingestion of soy-rich foods. Extensive molecular studies have been performed to determine its potential health benefits. The mechanism of action of genistein is complex and includes several cellular pathways. In addition to its estrogenic and/or antiestrogenic activities, genistein has been reported to inhibit steroidogenesis and block several protein tyrosine kinases, including epidermal growth factor receptor and src tyrosine kinases. Moreover, it arrests the cell cycle, induces apoptosis, and has antiangiogenic and antimetastatic properties and antioxidant activity. Herein, we review the current literature on the molecular mechanisms of genistein in relation to its effects on prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16197614     DOI: 10.3816/cgc.2005.n.021

Source DB:  PubMed          Journal:  Clin Prostate Cancer        ISSN: 1540-0352


  11 in total

1.  Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC-MS/MS method: Application to an oral bioavailability study of genistein in mice.

Authors:  Zhen Yang; Wei Zhu; Song Gao; Haiyan Xu; Baojian Wu; Kaustubh Kulkarni; Rashim Singh; Lan Tang; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2010-03-16       Impact factor: 3.935

2.  Specific oligopeptides in fermented soybean extract inhibit NF-κB-dependent iNOS and cytokine induction by toll-like receptor ligands.

Authors:  Woo Hyung Lee; Hong Min Wu; Chan Gyu Lee; Dae Il Sung; Hye Jung Song; Toshiro Matsui; Han Bok Kim; Sang Geon Kim
Journal:  J Med Food       Date:  2014-09-03       Impact factor: 2.786

3.  Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.

Authors:  Maarten C Bosland; Ikuko Kato; Anne Zeleniuch-Jacquotte; Joanne Schmoll; Erika Enk Rueter; Jonathan Melamed; Max Xiangtian Kong; Virgilia Macias; Andre Kajdacsy-Balla; L H Lumey; Hui Xie; Weihua Gao; Paul Walden; Herbert Lepor; Samir S Taneja; Carla Randolph; Michael J Schlicht; Hiroko Meserve-Watanabe; Ryan J Deaton; Joanne A Davies
Journal:  JAMA       Date:  2013-07-10       Impact factor: 56.272

4.  Evaluation of phytoestrogens in inducing cell death mediated by decreasing Annexin A1 in Annexin A1-knockdown leukemia cells.

Authors:  Masyitah Hasan; Endang Kumolosasi; Malina Jasamai; Jamia Azdina Jamal; Norazrina Azmi; Nor Fadilah Rajab
Journal:  Daru       Date:  2020-01-07       Impact factor: 3.117

5.  Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone loss.

Authors:  Russell T Turner; Urszula T Iwaniec; Juan E Andrade; Adam J Branscum; Steven L Neese; Dawn A Olson; Lindsay Wagner; Victor C Wang; Susan L Schantz; William G Helferich
Journal:  Menopause       Date:  2013-06       Impact factor: 2.953

6.  The functional significance of microRNA-145 in prostate cancer.

Authors:  M S Zaman; Y Chen; G Deng; V Shahryari; S O Suh; S Saini; S Majid; J Liu; G Khatri; Y Tanaka; R Dahiya
Journal:  Br J Cancer       Date:  2010-06-29       Impact factor: 7.640

7.  Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells.

Authors:  Vinita Singh-Gupta; Hao Zhang; Sanjeev Banerjee; Dejuan Kong; Julian J Raffoul; Fazlul H Sarkar; Gilda G Hillman
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

8.  Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

Authors:  Mohd Saif Zaman; Varahram Shahryari; Guoren Deng; Sobha Thamminana; Sharonjot Saini; Shahana Majid; Inik Chang; Hiroshi Hirata; Koji Ueno; Soichiro Yamamura; Kamaldeep Singh; Yuichiro Tanaka; Z Laura Tabatabai; Rajvir Dahiya
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

9.  In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol.

Authors:  Robert Michael Hermann; Hendrik Andreas Wolff; Hubertus Jarry; Paul Thelen; Carsten Gruendker; Margret Rave-Fraenk; Heinz Schmidberger; Hans Christiansen
Journal:  Radiat Oncol       Date:  2008-07-14       Impact factor: 3.481

10.  Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.

Authors:  Mohd Saif Zaman; Sobha Thamminana; Varahram Shahryari; Takeshi Chiyomaru; Guoren Deng; Sharanjot Saini; Shahana Majid; Shinichiro Fukuhara; Inik Chang; Sumit Arora; Hiroshi Hirata; Koji Ueno; Kamaldeep Singh; Yuichiro Tanaka; Rajvir Dahiya
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.